GlassScriptPhysician profile
Kimberly Laughman
NPI 1275093379
$1,080.88
in general payments reported to CMS, 2019-2025
13 companies · $556 in 2025
The $556 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.38 · 2023: $113 · 2024: $393 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.27 | 2024-2025 | |
| Hologic Sales and Service, LLC | $256.69 | 2023-2025 | Myosure Tissue Removal Device, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $162.87 | 2022-2025 | Jada System |
| Coopersurgical, INC. | $79.29 | 2023-2025 | Paragard T 380a, Endosee |
| Mayne Pharma Commercial LLC | $73.83 | 2024-2025 | |
| Exeltis, USA INC. | $68.40 | 2024-2025 | Slynd |
| Boston Scientific Corporation | $36.31 | 2023 | Advantage System |
| Bayer Healthcare Pharmaceuticals INC. | $27.89 | 2025 | |
| Exact Sciences Corporation | $25.29 | 2025 | The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $24.58 | 2025 | Myfembree |
| Millicent US INC | $23.83 | 2025 | Femlyv |
| Shield Therapeutics INC | $23.69 | 2023 | Accrufer |
| Gynesonics, INC. | $17.94 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Laughman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.